Skip to main content
logo
Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.330
+0.090 (4.02%)
Jul 31, 2026, 4:08 PM HKT

Hua Medicine (Shanghai) Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
492.93492.93255.8976.6117.6-
Revenue Growth
32.99%92.63%234.02%335.31%--
Gross Profit
280.36280.36124.7237.377.69-
Operating Income
-144.88-144.88-360.31-338.07-267.12-321.67
Net Income
1,1061,106-250.14-211.23-203.51-325.73
Earnings Per Share
1.101.10-0.25-0.22-0.21-0.34
EPS Growth
0.76%-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0921,0921,1401,461490.63675.24
Total Debt
301.67301.67300.18167.7597.5871.53
Net Cash (Debt)
790.62790.62839.571,293393.05603.71
Net Cash Growth
5.17%-5.83%-35.07%228.98%-34.89%-36.54%
Net Cash Per Share
0.790.790.861.320.410.63

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-52.15-52.15-417.97889.37-230.11-272.98
Capital Expenditures
-7.55-7.55-2.83-9.74-4.56-20.2
Free Cash Flow
-59.7-59.7-420.8879.63-234.67-293.18
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
56.88%56.88%48.74%48.79%43.69%-
Operating Margin
-29.39%-29.39%-140.80%-441.28%-1517.80%-
Pretax Margin
224.44%224.44%-97.75%-275.73%-1156.36%-
Profit Margin
224.44%224.44%-97.75%-275.73%-1156.36%-
FCF Margin
-12.11%-12.11%-164.44%1148.19%-1333.44%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
1.902.47----
Forward PE
-16.0530.5430.5429.00-
P/FCF Ratio
---1.99--
PS Ratio
4.235.555.2622.85181.75-